FDA Inspection 1041210 — Cardinal Biologicals, Inc.
The FDA completed an inspection of Cardinal Biologicals, Inc. on Feb 6, 2018 in Cape Girardeau, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cape Girardeau, MO (United States)